Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Resources
Interactive Tools
Sponsored
Biomarker Consortium
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
ASCO 2018 News - Episode 5
Practice Changes for Use of Immunotherapy in NSCLC
June 2, 2018
EP. 1: OncLive News Network On Location: In Chicago Friday, June 1
EP. 2: OncLive News Network On Location: In Chicago Saturday, June 2
EP. 3: OncLive News Network On Location: In Chicago Sunday, June 3
EP. 4: OncLive News Network On Location: In Chicago Monday, June 4
Now Viewing
EP. 5: Practice Changes for Use of Immunotherapy in NSCLC
EP. 6: ASCO 2018: Dr. Borghaei Highlights Immunotherapy Findings in Lung Cancer
EP. 7: ASCO 2018: Dr. Esteva Highlights CDK4/6 Inhibitors and More in Breast Cancer
EP. 8: ASCO 2018: Dr. Burris Highlights TAILORx and More in Breast Cancer
EP. 9: ASCO 2018: Dr. Lonial Highlights CAR T-Cell Therapy and More in Myeloma
EP. 10: ASCO 2018: Dr. Weber Highlights Exciting Abstracts in Melanoma
EP. 11: ASCO 2018: Dr. Coleman Shares Insight on Ongoing Research in Ovarian Cancer
EP. 12: ASCO 2018: Dr. Bekaii-Saab Highlights Pancreatic Cancer Abstracts
EP. 13: ASCO 2018: Dr. Birrer on Practice-Changing Ovarian Cancer Studies
EP. 14: ASCO 2018: Dr. Westin Sheds Light on PARP Inhibitor Abstracts in Ovarian Cancer
EP. 15: KEYNOTE Trial Data: Pembrolizumab's Role in NSCLC
EP. 16: Actual Use of Pembrolizumab and Chemotherapy in NSCLC
EP. 17: CheckMate-227: Testing Ipilimumab/Nivolumab in NSCLC
EP. 18: IMPower150: Implications for the Treatment of NSCLC
EP. 19: Important Data in the Squamous NSCLC Population
EP. 20: Impact of Data on the Real-Life Treatment of NSCLC
EP. 21: Tumor Mutational Burden in NSCLC: Should it be Routine?
EP. 22: Optimizing Immunotherapy in the NSCLC Treatment Paradigm
EP. 23: Using Immunotherapy Beyond Progression in NSCLC
EP. 24: Practice Changes for Use of Immunotherapy in NSCLC: Q&A
Related Content:
ASCO 2018 News
Breast Cancer
HER2+ Breast Cancer
Multiple Myeloma
Lung Cancer
FDA Receives New BLA for Dato-DXd in Pretreated EGFR+ Advanced NSCLC
Genomic Predictors Inform the Evolving Role of Chemotherapy in Breast Cancer Management
E-602 Plus Cemiplimab Elicits Preliminary Antitumor Activity, Is Safe in PD-(L)1–Resistant Solid Tumors